User profiles for Matthew F Pullen
 | Matthew PullenAssistant Professor of Internal Medicine/Infectious Diseases, University of Minnesota Verified email at umn.edu Cited by 3099 |
[HTML][HTML] A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19
DR Boulware, MF Pullen, AS Bangdiwala… - New England journal …, 2020 - Mass Medical Soc
Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …
Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial
…, DA Williams, EC Okafor, MF Pullen… - Annals of internal …, 2020 - acpjournals.org
Background: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
Objective: To investigate whether hydroxychloroquine could reduce COVID-19 severity in …
[HTML][HTML] Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19
…, HG Saveraid, WJ Tordsen, MF Pullen… - … England Journal of …, 2022 - Mass Medical Soc
Background Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an
important component of the comprehensive response to the severe acute respiratory …
important component of the comprehensive response to the severe acute respiratory …
[HTML][HTML] Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind …
…, CJ Tignanelli, JL Thompson, M Pullen… - The Lancet Infectious …, 2023 - thelancet.com
Background Post-COVID-19 condition (also known as long COVID) is an emerging chronic
illness potentially affecting millions of people. We aimed to evaluate whether outpatient …
illness potentially affecting millions of people. We aimed to evaluate whether outpatient …
Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and …
Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial
…, KA Pastick, ML Axelrod, MF Pullen… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
emerging virus causing the ongoing coronavirus disease 2019 (COVID-19) pandemic with no …
Symptoms of COVID-19 outpatients in the United States
MF Pullen, CP Skipper, KH Hullsiek… - Open forum …, 2020 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel
pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due …
pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due …
Cerebrospinal fluid early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials
Background In cryptococcal meningitis phase 2 clinical trials, early fungicidal activity (EFA)
of Cryptococcus clearance from cerebrospinal fluid (CSF) is used as a surrogate endpoint for …
of Cryptococcus clearance from cerebrospinal fluid (CSF) is used as a surrogate endpoint for …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
…, EC Okafor, CP Skipper, MF Pullen… - Open forum …, 2020 - academic.oup.com
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
[HTML][HTML] Blastomycosis—Some progress but still much to learn
Blastomycosis, caused by Blastomyces spp., is an endemic mycosis capable of causing
significant disease throughout the body. Higher rates of infection are seen in the Mississippi and …
significant disease throughout the body. Higher rates of infection are seen in the Mississippi and …
